Company / Capital Expenditures
ANAPTYSBIO, INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$87.0K
FY2025
5-year range
$87.0K / $807.0K
FY2021-FY2025
Trend
-75.7%
vs FY2024
Sector context
#170 of 194
Health Care
What the data says
ANAPTYSBIO, INC's capital expenditures of $87,000 is lower than 88% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $50,000 in FY2016 to $1M in FY2020.
Based on SEC 10-K filings.
$87,000 in FY2025 with a 5-year CAGR of -39.4%.
Declined from $807,000 to $87,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -46.5%
- 5-Year CAGR
- -39.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 194This company $87.0K Sector average $117.5M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -39.4%, indicating a declining trend.
- In FY2025, capital expenditures decreased 75.7% year-over-year.
- Ranks #170 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $87.0K | -75.7% |
| FY2024 | $358.0K | -55.6% |
| FY2023 | $807.0K | +41.8% |
| FY2022 | $569.0K | -29.3% |
| FY2021 | $805.0K | -24.3% |
| FY2020 | $1.1M | +266.6% |
| FY2019 | $290.0K | -72.7% |
| FY2018 | $1.1M | +346.6% |
| FY2017 | $238.0K | +376.0% |
| FY2016 | $50.0K | -79.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026